Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.13678 | 77 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.09505 | 76 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.09957 | 76 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.70345 | 72 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.73827 | 73 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.06114 | 77 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.03628 | 76 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.8258 | 74 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.15826 | 68 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.78989 | 73 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.85038 | 74 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.74502 | 73 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.89671 | 75 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.84841 | 74 |